MRVI – maravai lifesciences holdings, inc. - class a common stock (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MRVI

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/25

10:23 am

mrvi

Rating for MRVI

Low Report

Rating for MRVI

Report

3/25

10:23 am

mrvi

Rating for MRVI

Low Report

Rating for MRVI

Report

3/21

11:41 am

mrvi

Rating for MRVI

Low Report

Rating for MRVI

Report

2/26

07:35 am

mrvi

Rating for MRVI

Medium Report

Rating for MRVI

Report

2/26

07:35 am

mrvi

Rating for MRVI

Medium Report

Rating for MRVI

Report

2/26

07:17 am

mrvi

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $3.00 price target on the stock, down previously from $9.00.

Medium Report

Report

2/26

04:56 am

mrvi

Maravai Lifesciences downgraded to Neutral from Outperform at Baird

Medium Report

Maravai Lifesciences downgraded to Neutral from Outperform at Baird

Report

2/26

04:56 am

mrvi

Maravai Lifesciences downgraded to Neutral from Outperform at Baird

Medium Report

Maravai Lifesciences downgraded to Neutral from Outperform at Baird

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.